欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/H/0419/008
药品名称OLIMEL N12
活性成分
    • AMINO ACID MIXTURE 14.2 %
    • glucose 27.5 %
剂型Emulsion for infusion
上市许可持有人BAXTER SAS 6 avenue Louis Pasteur 78310 Maurepas
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Germany (DE)
      Olimel 7,6 % E, Emulsion zur Infusion
    • Denmark (DK)
    • Belgium (BE)
      OLIMEL N12, émulsion pour perfusion
    • Netherlands (NL)
    • Luxembourg (LU)
      Olimel N12, Emulsion pour perfusion
    • Iceland (IS)
      Olimel N12 innrennslislyf, fleyti
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      ZentroOLIMEL 7,6 % mit Elektrolyten - Emulsion zur Infusion
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Olimel N12
    • Finland (FI)
    • Czechia (CZ)
      OLIMEL N12E infuzní emulze
    • Slovenia (SI)
    • Malta (MT)
      TRIOMEL 12 g/l nitrogen 950 kcal/l with electrolytes, emulsion for infusion
许可日期2019/02/20
最近更新日期2024/03/04
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase